盐酸左米那普仑
Tier C — Watch / tradeLevomilnacipran Hydrochloride
Targets：NET、SERT
Brand：Fetzima
Indications (approved)：重度抑郁症
Regional status
Synthetic routes & intermediates4 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| LEVO-001 | - | (1S)-ethyl 2-(aminomethyl)-1-phenylcyclopropanecarboxylate |
| LEVO-002 | 810696-15-2 | (1S)-2-(aminomethyl)-1-phenylcyclopropanecarboxylic acid hydrochloride |
| LEVO-003 | - | (1S)-2-(aminomethyl)-1-phenylcyclopropanecarbonyl chloride hydrochloride |
| Code | CAS No. | Intermediate |
|---|---|---|
| LEVO-013 | 1001017-62-4 | - |
| LEVO-014 | 100-97-0 | 1,3,5,7-tetraazaadamantane |
| LEVO-015 | 109001-33-4 | 1-(((1R,2S)-2-(diethylcarbamoyl)-2-phenylcyclopropyl)methyl)-1,3,5,7-tetraazaadamantan-1-ium bromide |
| Code | CAS No. | Intermediate |
|---|---|---|
| LEVO-008 | 96847-53-9 | (1S,5R)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
| LEVO-009 | 172015-99-5 | - |
| LEVO-016 | 107-18-6 | - |
| LEVO-017 | 103-80-0 | - |
| LEVO-018 | 1797-74-6 | - |
| LEVO-019 | 145193-16-4 | - |
| LEVO-020 | 174848-98-7 | - |
| LEVO-021 | 106-95-6Available | - |
| LEVO-022 | 103-82-2 | - |
| LEVO-023 | 21490-59-5 | - |
| LEVO-024 | 1393058-97-3 | - |
| LEVO-025 | 1644291-41-7 | - |
| LEVO-026 | 403789-25-3 | - |
| Code | CAS No. | Intermediate |
|---|---|---|
| LEVO-004 | 51594-55-9 | (R)-2-(chloromethyl)oxirane |
| LEVO-005 | 140-29-4 | 2-phenylacetonitrile |
| LEVO-006 | 1535163-09-7 | (1S,2R)-2-(hydroxymethyl)-1-phenylcyclopropanecarbonitrile |
| LEVO-007 | 96847-51-7 | (1S,2R)-2-(hydroxymethyl)-1-phenylcyclopropanecarboxylic acid |
| LEVO-008 | 96847-53-9 | (1S,5R)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
| LEVO-009 | 172015-99-5 | (1S,2R)-N,N-diethyl-2-(hydroxymethyl)-1-phenylcyclopropanecarboxamide |
| LEVO-010 | 1237261-60-7 | (1S,2R)-2-(chloromethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide |
| LEVO-011 | 1074-82-4 | potassium 1,3-dioxoisoindolin-2-ide |
| LEVO-012 | 1237261-65-2 | (1S,2R)-2-((1,3-dioxoisoindolin-2-yl)methyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide |
Frequently asked questions
What are the approved indications of Levomilnacipran Hydrochloride?
Approved indications include: 重度抑郁症.
When does the Levomilnacipran Hydrochloride patent expire?
No public expiry year is available for Levomilnacipran Hydrochloride yet; this page updates once verified.
How many synthesis routes are recorded for Levomilnacipran Hydrochloride?
4 synthesis routes are recorded; the shortest is 2 steps with 10.95 kg (Levomilnacipran Hydrochloride) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Levomilnacipran Hydrochloride intermediates?
1 intermediate CAS of Levomilnacipran Hydrochloride are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Levomilnacipran Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24